Solitaire with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) Trial

Saver JL, Goyal M, Bonafe A, Diener H-C, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Haacke W, Jansen O, Jovin TG, Mattle HP, Nogueira RG, Siddiqui AH, Yavagal DR, Devlin TG, Lopes DK, Reddy V, du Mesnil de Rochemont R, Jahan R, for the SWIFT PRIME Investigators: Solitaire with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) Trial: Protocol for a Randomized, Controlled, Multicenter Study Comparing the Solitaire Revascularization Device with IV tPA with IV tPA Alone in Acute Ischemic Stroke. Int J Stroke 10:439-448, April 2015 (DOI 10.1111/ijs.12459). PMID 25777831

Please notify our office immediately if you have a fever, cough, runny nose, or shortness of breath or have been in contact with someone who has been diagnosed with COVID-19. UBNS is following all CDC and New York State Dept. of Health guidelines for preventing the spread of COVID-19. Due to increased call volume, hold times are longer than usual. We apologize for the inconvenience.